Mirador Therapeutics Funding: $650M Raised, Series B (2025)
Mirador Therapeutics is a Biotech company based in San Diego, California. It has raised $650M in total funding. Latest round: Series B.
Mirador Therapeutics funding overview
Mirador Therapeutics is a Biotech company based in San Diego, California. Mirador Therapeutics has raised $650M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Mirador Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include ARCH Venture Partners, OrbiMed, Fidelity Investments, Sanofi Ventures, T. Rowe Price, Adage Capital Partners and 11 others. 17 distinct backers are named across the disclosed rounds.
Mirador Therapeutics at a glance
Total raised
$650M
Latest round
Series B
Latest round date
January 2025
Industry
Biotech
Headquarters
San Diego, California
Notable investors
ARCH Venture Partners, OrbiMed, Fidelity Investments, Sanofi Ventures, T. Rowe Price, Adage Capital Partners, Point72, Fairmount
Frequently asked about Mirador Therapeutics funding
How much has Mirador Therapeutics raised?
Mirador Therapeutics has raised $650M in total disclosed funding across the rounds on record.
Who has invested in Mirador Therapeutics?
ARCH Venture Partners, OrbiMed, Fidelity Investments, Sanofi Ventures, T. Rowe Price, Adage Capital Partners are named among the investors backing Mirador Therapeutics.
What was the latest Mirador Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2025.
Where is Mirador Therapeutics based?
Mirador Therapeutics is based in San Diego, California.
What sector does Mirador Therapeutics operate in?
Mirador Therapeutics is tracked under Biotech from San Diego, California, with $650M in disclosed funding.
When did Mirador Therapeutics last raise?
The last disclosed Mirador Therapeutics round closed in January 2025 at Series B.
Mirador Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Diego below to benchmark round size and investor mix.
